Active, not recruiting
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
NCT06517758
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Honor Health Research Institute Scottsdale, Arizona, United States
- Fullerton Neuro and Headache Ctr Fullerton, California, United States
- California Pacific Medical Center Sacramento, California, United States
- Augusta University Georgia Augusta, Georgia, United States